NSCIF (Nanalysis Scientific) Debt-to-EBITDA : N/A (As of Mar. 2026)

Name: Nanalysis Scientific Corp (NSCIF) — Historical Annual & Quarterly Data
Creator: GuruFocus
License: https://www.gurufocus.com/terms-of-service.php

Nanalysis Scientific Corp NSCIF

51 GF Score

Price $0.09

GF Value $0.21

Valuation Possible Value Trap

4 Warning Signs

View Full Analysis

What is Nanalysis Scientific Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nanalysis Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $5.54 Mil. Nanalysis Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $5.30 Mil. Nanalysis Scientific's annualized EBITDA for the quarter that ended in Mar. 2026 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Nanalysis Scientific's Debt-to-EBITDA or its related term are showing as below:

NSCIF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -20.8 Med: -1.94 Max: 4.35
Current: -16.78

During the past 8 years, the highest Debt-to-EBITDA Ratio of Nanalysis Scientific was 4.35. The lowest was -20.80. And the median was -1.94.

NSCIF's Debt-to-EBITDA is ranked worse than
100% of 1795 companies
in the Hardware industry
Industry Median: 1.73 vs NSCIF: -16.78

Nanalysis Scientific (OTCPK:NSCIF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Nanalysis Scientific Debt-to-EBITDA Related Terms

Nanalysis Scientific Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Nanalysis Scientific's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanalysis Scientific Debt-to-EBITDA Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Debt-to-EBITDA

Get a 7-Day Free Trial

4.35

-2.04

-1.86

-2.40

-20.79

Nanalysis Scientific Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Debt-to-EBITDA	Get a 7-Day Free Trial															-1,394.25	-5.58	-13.28	17.13	N/A

NSCIF vs COHR, KEYS, GRMN: Debt-to-EBITDA Comparison

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanalysis Scientific Debt-to-EBITDA vs Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's Debt-to-EBITDA falls into.

Save Embed

51GF Score

Nanalysis Scientific Corp NSCIF

Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nanalysis Scientific Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nanalysis Scientific's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(7.66	+	5.082)	/	-0.613
	=	-20.79

Nanalysis Scientific's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(5.539	+	5.297)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Is Nanalysis Scientific (NSCIF) Overvalued in 2026?

Based on GuruFocus' analysis, Nanalysis Scientific stock appears to be undervalued. The current stock price of $0.09 is trading 56.1% below its estimated GF Value™ of $0.21. GuruFocus considers Nanalysis Scientific to be Possible Value Trap.

Key valuation signals for NSCIF:

Debt-to-EBITDA: N/A
GF Value™: $0.21 vs. price of $0.09 (56.1% below fair value)
GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the NSCIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanalysis Scientific Business Description

Industry Technology Hardware

Comparable Companies TSXV:EDY TSXV:JTC XCNQ:MARY TSXV:PALS TSE:6861 COHR KEYS GRMN TDY TPE:2360 MKSI OSTO:HEXA B FTV TRMB SZSE:300567 CGNX ESE SZSE:002414 TSE:6856 TSE:7701

Other Exchanges 1N1:Germany NSCI:Canada

Address Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T3J 5J9

Website https://www.nanalysis.com

Nanalysis Scientific Corp has two primary operating segments. Its first operating segment, Scientific Equipment, conducts scientific equipment manufacturing and sales, mainly as a patent-protected technology company that develops, manufactures, and sells magnetic resonance products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science, and medical applications. Its second operating segment, Security Services, focuses on providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. The majority of this segment consists of servicing a Crown Corporation of the Government of Canada, maintaining imaging and security equipment at international airports across Canada.

51GF Score

Get the complete analysis for NSCIF

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09

Price

$0.21

GF Value

View NSCIF Analysis

See Debt-to-EBITDA data for all stocks →